MRI vs ultrasound for liver cancer detection in high-risk people
Part of Cancer, Digestive system clinical trials.
This trial compares two types of scans to see which detects liver cancer better in people at high risk. You would receive either an MRI with contrast or an ultrasound every 6 months to monitor for liver cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have liver cirrhosis caused by alcohol, fatty liver disease, hepatitis B or C, or genetic hemochromatosis
- You have a liver health score (Child Pugh A or B) that is mild to moderate
- You have at least a 3% yearly risk of getting liver cancer, or you have been treated for liver cancer before and are now back on regular ultrasound checks
- You do not have any metal implants or severe kidney problems, and you are not pregnant or breastfeeding
- You are not a prisoner and have not had a liver transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a shorter, non-contrast MRI and ultrasound to monitor for liver cancer in people with cirrhosis whose ultrasound images aren’t clear enough. It aims to see which method works better and may help you get safer, more reliable follow-up.
This study compares ultrasound scans versus MRI scans to see which one better helps prevent deaths from liver cancer in people with cirrhosis. You may be assigned to one of the two imaging tests and follow-up visits to track whether liver cancer develops or is caught early.
This trial compares two types of imaging scans (CEUS and AMRI) to see which one is better at finding liver cancer (HCC) in patients who have an unclear spot on their liver (an indeterminate nodule). It is for people with cirrhosis who have at least one such nodule but no confirmed liver cancer yet.
This study looks at ways to improve screening for liver cancer in adults with long-term liver disease. It may help catch liver cancer earlier, which can make treatment easier.
This trial studies a faster MRI scan to help track early liver cancer in people who have cirrhosis and are considered high risk. It may improve how often and how well doctors can look for changes without using longer imaging sessions.
This study uses a special MRI machine to take detailed images of the liver. It includes people newly diagnosed with liver cancer who haven't had treatment yet, as well as healthy volunteers for comparison. The goal is to see how well the machine works for different patients.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.